Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How good is your screening library?

John J Irwin1

  • 1Department of Pharmaceutical Chemistry, University of California San Francisco, 1700 4th St, San Francisco, CA 94143-2550, USA. jji@cgl.ucsf.edu

Current Opinion in Chemical Biology
|June 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Selectivity Implications of Docking Libraries with Greater and Lesser Similarities to Bio-like Molecules.

Journal of medicinal chemistry·2026
Same author

Library docking for Cannabinoid-2 Receptor ligands.

bioRxiv : the preprint server for biology·2026
Same author

Large Library Docking for Polypharmacology.

Journal of medicinal chemistry·2026
Same author

The selectivity implications of docking libraries with greater and lesser similarities to bio-like molecules.

bioRxiv : the preprint server for biology·2026
Same author

CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Journal of chemical information and modeling·2026
Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
Same journal

Chemigenetic fluorescent biosensors in biological imaging - New trends and advances.

Current opinion in chemical biology·2026
See all related articles

Designing effective screening libraries is key for discovering new drug leads. Libraries with intermediate molecular complexity, free of artifacts, offer a balanced approach for drug discovery and chemical biology research.

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Drug Discovery

Background:

  • Efficient library design is crucial for identifying novel protein ligands.
  • Current strategies focus on incorporating novel chemical matter or excluding non-productive compounds.
  • There's a growing understanding of molecular complexity's impact on screening outcomes.

Purpose of the Study:

  • To explore the optimal molecular complexity for screening libraries.
  • To balance hit rates and the resemblance of compounds to final drug candidates.
  • To identify characteristics of general-purpose screening libraries.

Main Methods:

  • Analysis of screening library design principles.
  • Evaluation of small versus large molecule screening characteristics.

Related Experiment Videos

  • Consideration of molecular complexity and its implications for hit rates and affinities.

    • Main Results:

    • Small molecules offer high hit rates but low affinities, requiring high concentrations.
    • Large molecules may resemble final drugs but have significantly lower hit rates.
    • Intermediate complexity libraries, free of nuisance compounds, are proposed as optimal.

    Conclusions:

    • The optimal screening library balances compound size and complexity.
    • Intermediate complexity libraries provide a practical approach for drug discovery.
    • Excluding artifact-causing compounds enhances library utility.